Financing Entrepreneurial Excellence
SironRx, a spinoff of Juventas Therapeutics, is developing novel therapies that promote wound repaid and prevent dermal scarring.
SironRx Closes $2.3 Million Series A Early Stage Venture Capital Investment
Find Out More About ESP
Mike Bunker manages the Early Stage Partners investment in SironRX